Introduction
malignancy, Prostate cancer, cancer deaths
RECURRENCE, LYMPH NODE METASTASES, OLIGOMETASTATIC DISEASE, METASTATIC TUMOUR, PROSTATE CANCER, METASTASES
Prostate cancer (PCa) is the most common type of malignancy in men, accounting for 10% of all cancer deaths among men within the European Union (EU) [Correct localisation of BCR is essential for further treatment planning, since potentially curative treatment is feasible in local recurrence or locoregional lymph node metastases, whereas in distant metastases, (palliative) systemic treatment should be considered. Moreover, there is currently an increasing interest in metastasis-directed therapies (MDTs) in patients with minimal metastatic tumour burden (oligometastatic disease) [[Various radiolabelled anti-PSMA small molecules and monoclonal antibodies have been used to detect PCa recurrence. In this study, we aimed to compare the per-patient detection rates (DR) of [